Print Page

其 他 安 全 警 示

 
The United States: FDA identifies cases of serious liver injury in patients taking Tavneos (avacopan) for severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (English only)
 
 
 
附件:
 
back